Mannose binding protein for use in anti-hiv treatment

Details Mannose binding protein for use in anti-hiv treatment Mannose binding protein for use in anti-hiv treatment

A - Human Necessities

61

K

A61K 38/16 (2006.01) A61K 38/17 (2006.01) A61P 31/18 (2006.01) A61P 37/04 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2472438

It is intended to disclose an anti-HIV agent which contains as the active ingredient a mannose-binding protein (MBP) and efficaciously contributes to the treatment of patients infected with human immunodeficiency virus (HIV) and inhibits the progress of the disease. It is also intended to disclose a method of evaluating an anti-HIV activity exerted by the MBP which involves the step of culturing HIV-infected cells in the presence of the MBP.

Cette invention concerne un agent anti-HIV qui contient comme principe actif une protéine de fixation du mannose (MBP) et qui contribue efficacement au traitement de patients infectés par le virus de l'immunodéficience humaine (HIV) et inhibe la progression de la maladie. Cette invention concerne également un procédé servant à évaluer l'activité anti-HIV de la protéine MBP, ce procédé consistant à cultiver des cellules infectées par le virus HIV en présence de la protéine MBP.

Affiliated with

Also associated with

Rating

Mannose binding protein for use in anti-hiv treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mannose binding protein for use in anti-hiv treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mannose binding protein for use in anti-hiv treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2056727